Interestingly, similar results were observed when comparing sarcomas obtained from Tp53-H; Prl2-KO with those derived from Tp53-H mice, where we observed a significant 34% reduction in tumor proliferation and no change in apoptosis (Supplementary Fig. S3A–S3C). This evidence concerns the gene TP53 and neoplasm.